FORT LAUDERDALE, Fla., Nov. 25, 2020 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that its management team is scheduled to participate in the Piper Sandler 32nd Annual Healthcare Conference, which is scheduled to take place virtually from December 1-3, 2020.
Tim Moran, Chief Executive Officer of Motus GI, will participate in a fireside chat that will be available via webcast on the Piper Sandler conference site (click here) from November 25th to December 3rd, and on the Events page on the Company’s website, www.motusgi.com. An archive of the webcast will continue to be available on the Company’s website for 90 days.
In addition, the Motus GI management team will be participating in 1×1 meetings on December 2, 2020, meetings may be requested exclusively via Piper Sandler.
About Motus GI
Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions.
For more information, visit www.motusgi.com and connect with the Company on Twitter, LinkedIn and Facebook.
Investor Contact:
Bob Yedid
LifeSci Advisors
(646) 597-6989
bob@lifesciadvisors.com
Proposed business combination to create a North American technology company with an AI-driven fintech marketplace.…
NEW YORK, NY / ACCESSWIRE / March 25, 2024 / Chronic pain affects millions of…
Oakville, Ontario--(Newsfile Corp. - March 25, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)…
Conference call to discuss financial and operational results scheduled for Tuesday, March 26 at 8:30…
VANCOUVER, BC / ACCESSWIRE / March 25, 2024 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the…
ORLANDO, FL / ACCESSWIRE / March 25, 2024 / Black Book Research, the premier source…